From May 15 to 17, 2025, the 2025 Hebei Biomedical Industry Expo and the 15th China (Shijiazhuang) International Pharmaceutical Expo, jointly organized by the Hebei Pharmaceutical Association and Hebei International Exhibition Center, and co-organized by the China Council for the Promotion of International Trade Hebei Committee and Hebei Health Commission, was successfully held at Shijiazhuang International Convention and Exhibition Center.This expo thoroughly implemented Hebei Province's high-quality development strategy for the biomedical industry. By establishing an international platform integrating technology display, industry-finance docking, and policy coordination, it effectively empowered industrial innovation and upgrading as well as regional resource integration, becoming an important engine for promoting the construction of the Beijing-Tianjin-Hebei biomedical ecosystem.
As an exhibitor, Shijiazhuang Discoverway made a splendid appearance with three mature core business projects: TCM R&D technical services, chemical drug R&D technical services, and small molecule drug synthesis customization services. Through in-depth exchanges with industry experts, partners and clients, fruitful results were achieved!
Part1: TCM R&D Technical Services
Discoverway TCM Research Institute is led by chief scientists including top domestic TCM experts and PhD holders, bringing together an interdisciplinary team of more than 20 PhDs and masters.The team covers all fields including TCM theory, herbal identification, processing technology, dosage optimization, and formulation development. Core members come from large domestic TCM enterprises with rich experience in TCM research, development and industrialization.The team has cumulatively declared over 30 innovative TCM drugs/improved new drugs, led the development of classical famous prescriptions, generic same-formula drugs, hospital preparations, etc., with a 100% industrialization rate for technology transfer and improvement projects.
[TCM Project Recommendations]
Part2: Chemical Drug R&D Technical Services
Discoverway Chemical Drug Research Institute focuses on the subdivision field of small molecule generic liquid preparations, deeply cultivates the development of dosage forms such as oral solutions, injections, and inhalation preparations, and has formed a dual-wheel R&D model of "clinical demand orientation + process pain point breakthrough".Currently, 24 generic drug development projects have been completed, with 16 varieties entering the registration application acceptance stage, covering therapeutic areas such as anti-tumor, anti-infection, and respiratory system, serving a total of 11 pharmaceutical companies to achieve technology transfer.
[Chemical Drug Project Recommendations]
Part3: Small Molecule Drug Synthesis Customization Services
Discoverway Small Molecule Synthesis Research Institute has established a high-quality, professional R&D team with 100% of core members holding bachelor's degrees or higher, and has invited authoritative experts from the Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences to form an advisory team.Discoverway Small Molecule Synthesis Research Institute has established a high-quality, professional R&D team with 100% of core members holding bachelor's degrees or higher, and has invited authoritative experts from the Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences to form an advisory team.
[Small Molecule Compound Recommendations]
This exhibition effectively achieved the practical goals of precise technical communication, localized industry connections, and concrete brand recognition, further consolidating our company's participation value in the regional biomedical innovation ecosystem.In the future, Discoverway will continue to use the exhibition results as a fulcrum, and contribute differentiated technical support to the domestic pharmaceutical industry cluster by optimizing the agile service system of "R&D-process scale-up".